Cargando…

Gemcitabine-based chemotherapy as a viable option for treatment of advanced breast cancer patients: a meta-analysis and literature review

This meta-analysis was designed to compare the efficacy and safety of gemcitabine-based regimens for the treatment advanced breast cancer (ABC). Altogether 15 studies involving 8195 ABC patients were retrieved for analysis. Compared with non-gemcitabine-based chemotherapies, patients receiving gemci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Zhibo, Zhang, Yifan, Jin, Chen, Fu, Deliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805543/ https://www.ncbi.nlm.nih.gov/pubmed/29467957 http://dx.doi.org/10.18632/oncotarget.23426

Ejemplares similares

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
por: de Jesus, Victor H. F., et al.
Publicado: (2020)

Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis
por: Lu, Wenjie, et al.
Publicado: (2022)

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
por: Citterio, Chiara, et al.
Publicado: (2018)

A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer
por: Ge, Long, et al.
Publicado: (2017)

Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis
por: Zhan, Qiao-Hui, et al.
Publicado: (2017)

Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
por: Bai, Xue-Song, et al.
Publicado: (2022)

Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis
por: Sun, Jinping, et al.
Publicado: (2017)

Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis
por: Chu, Wei, et al.
Publicado: (2017)

Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer
por: Li, Zhong-Hui, et al.
Publicado: (2022)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
por: Li, Zhen-Yu, et al.
Publicado: (2020)

Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
por: Caswell-Jin, Jennifer L, et al.
Publicado: (2018)

Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A meta-analysis
por: Wu, Pei, et al.
Publicado: (2021)

Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
por: Cho, Yo-Han, et al.
Publicado: (2017)

Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials
por: He, Zheng, et al.
Publicado: (2017)

Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis
por: Yu, Jian-Hong, et al.
Publicado: (2021)

Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
por: Chang, Seong-Hwan, et al.
Publicado: (2017)

Accuracy of ultrasound elastography for predicting breast cancer response to neoadjuvant chemotherapy: A systematic review and meta-analysis
por: Chen, Wei, et al.
Publicado: (2022)

Surgery plus chemotherapy versus chemotherapy alone in primary intestinal lymphoma: a meta-analysis
por: Shu, Yefei, et al.
Publicado: (2021)

Comparative effectiveness of treatment options for subacromial shoulder conditions: a systematic review and network meta-analysis
por: Babatunde, Opeyemi O., et al.
Publicado: (2021)

Assessment of the safety and efficacy of combination chemotherapy and PD-1/PD-L1 inhibitor treatment of breast cancer: A meta-analysis
por: Qian, Da, et al.
Publicado: (2023)

Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy for Metastatic Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Lu, Fei, et al.
Publicado: (2021)

Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials
por: Yang, Shou-Bo, et al.
Publicado: (2017)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
por: Jin, Zhe, et al.
Publicado: (2020)

Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis
por: Zhang, Liulu, et al.
Publicado: (2022)

Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
por: Zhao, Zi-Yi, et al.
Publicado: (2017)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Association between Dietary Cadmium Exposure and Breast Cancer Risk: An Updated Meta-Analysis of Observational Studies
por: Wu, Xiujuan, et al.
Publicado: (2015)

Association between Four MMP-9 Polymorphisms and Breast Cancer Risk: A Meta-Analysis
por: Zhang, Xiaoli, et al.
Publicado: (2015)

Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis
por: Fu, Yijie, et al.
Publicado: (2016)

Treatments for patients with advanced neuroendocrine tumors: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2019)

Effect of neoadjuvant chemotherapy followed by surgery for FIGO stage I–II cervical cancer: a meta-analysis
por: Yang, Shu-Li, et al.
Publicado: (2020)

Effect of music therapy on chemotherapy-induced nausea and vomiting in gastrointestinal cancer: A systematic review and meta-analysis
por: Zhong, Fang-Ping, et al.
Publicado: (2023)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment
por: Su, Qiang, et al.
Publicado: (2017)

Quantitation of cell-free DNA in blood is a potential screening and diagnostic maker of breast cancer: a meta-analysis
por: Wang, Huadi, et al.
Publicado: (2017)

The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis
por: Sun, Xin-Fang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oll0o289s8ae5dsf8vo86drosj